Product Description
Product Name: Hertraz 440 mg Injection
Active Ingredient: Trastuzumab
Strength: 440 mg
Form: Lyophilized Powder for Intravenous Infusion
Category: Monoclonal Antibody / HER2-Targeted Therapy
Indication: HER2-Positive Breast Cancer, HER2-Positive Gastric (Stomach) Cancer
Hertraz 440 mg Injection contains Trastuzumab, a targeted monoclonal antibody used in the treatment of HER2-positive breast and gastric cancers. It works by binding to the HER2 receptor, a protein found in high amounts on some cancer cells, thereby inhibiting their growth and survival.
